共 44 条
[1]
Sytkowski P.A.(1996)Secular trends in long term sustained hypertension, long term treatment and cardiovascular mortality: the Framingham Heart Study 1950 to 1990 Circulation 93 697-703
[2]
D’Agostino R.B.(1990)Blood pressure, stroke and coronary heart disease. Part I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias Lancet 335 765-74
[3]
Belanger A.J.(2006)Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004) Hypertens Res 29 S1-105
[4]
MacMahon S.(2003)National Heart, Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report JAMA 289 2560-72
[5]
Peto R.(2003)2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension J Hypertens 21 1011-53
[6]
Cutler J.(2003)2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension J Hypertens 21 1983-92
[7]
Chobanian A.V.(1999)World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension J Hypertens 17 151-83
[8]
Bakris G.L.(2006)Controlled-release nifedipine and valsartan combination therapy in patients with essential hypertension: the Adalat CR and valsartan cost-effectiveness combination (ADVANCE-Combi) study Hypertens Res 29 789-96
[9]
Black H.R.(2000)Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension Drugs 59 141-57
[10]
Whitworth J.A.(1993)Clinical assessment of combination therapy development Blood Press 2 5-9